In the course of routine medical care, a drug’s safety and efficacy are subject to countless unique judgments as part of an ethic called informed consent. Practicing this ethic in the care of persons with mental illness presents unique challenges. This talk will review these challenges in order to better understand how patients and providers actually make a decision to use a drug. Topics will include the ability to make a decision, surrogate decision making, how people evaluate uncertainty, and decision making styles in the setting of uncertainty. These data will allow the audience to consider a core question: is there adequate correspondence among the evidence about how patients make decisions, how policy makers assess and judge a drug’s safety and efficacy, and the promotion of drugs in the medical marketplace?
Back to S114 Cerebrovascular Risks in the Elderly: What Every Clinician Should Know
Back to Satellite Symposia
Back to The Eleventh International Congress